PURPOSE: The objectives of this study were to evaluate 1) the feasibility of performing computerized tests of low luminance visual acuity (LLVA), cone-specific contrast (Cone Contrast Test [CCT]), contrast sensitivity, and microperimetry and 2) the test-retest repeatability of these outcomes in dry age-related macular degeneration (AMD). METHODS: This prospective study enrolled 30 subjects at a single site (8 controls, 8 early AMD, and 12 intermediate AMD). Subjects underwent LLVA, contrast sensitivity, CCT, and microperimetry with eye tracking. Low luminance deficit was defined as best-corrected visual acuity minus LLVA in EDTRS letters. Follow-up testing was administered at approximately 1 month. RESULTS: There was high test-retest repeatability at one month for all visual function metrics (intraclass correlations >0.7) except log contrast sensitivity (intraclass correlations 0.6). Compared with controls, patients with intermediate AMD showed significant deficits on best-corrected visual acuity, LLVA, low luminance deficit, percent-reduced threshold on microperimetry, and red CCT (P < 0.05), but not on contrast sensitivity, green and blue CCT. CONCLUSION: This pilot study supports the feasibility and reliability of using LLVA, microperimetry, and CCT in early dry AMD. Our data suggest these measures can be used as alternative future clinical trial endpoints. A larger, prospective natural history study of alternative visual function measures in dry AMD is warranted.
PURPOSE: The objectives of this study were to evaluate 1) the feasibility of performing computerized tests of low luminance visual acuity (LLVA), cone-specific contrast (Cone Contrast Test [CCT]), contrast sensitivity, and microperimetry and 2) the test-retest repeatability of these outcomes in dry age-related macular degeneration (AMD). METHODS: This prospective study enrolled 30 subjects at a single site (8 controls, 8 early AMD, and 12 intermediateAMD). Subjects underwent LLVA, contrast sensitivity, CCT, and microperimetry with eye tracking. Low luminance deficit was defined as best-corrected visual acuity minus LLVA in EDTRS letters. Follow-up testing was administered at approximately 1 month. RESULTS: There was high test-retest repeatability at one month for all visual function metrics (intraclass correlations >0.7) except log contrast sensitivity (intraclass correlations 0.6). Compared with controls, patients with intermediateAMD showed significant deficits on best-corrected visual acuity, LLVA, low luminance deficit, percent-reduced threshold on microperimetry, and red CCT (P < 0.05), but not on contrast sensitivity, green and blue CCT. CONCLUSION: This pilot study supports the feasibility and reliability of using LLVA, microperimetry, and CCT in early dry AMD. Our data suggest these measures can be used as alternative future clinical trial endpoints. A larger, prospective natural history study of alternative visual function measures in dry AMD is warranted.
Authors: P S Moke; A H Turpin; R W Beck; J M Holmes; M X Repka; E E Birch; R W Hertle; R T Kraker; J M Miller; C A Johnson Journal: Am J Ophthalmol Date: 2001-12 Impact factor: 5.258
Authors: B Weingessel; S Sacu; P V Vécsei-Marlovits; A Weingessel; S Richter-Mueksch; U Schmidt-Erfurth Journal: Eye (Lond) Date: 2008-08-01 Impact factor: 3.775
Authors: Anne S Lindblad; Patricia C Lloyd; Traci E Clemons; Gary R Gensler; Frederick L Ferris; Michael L Klein; Jane R Armstrong Journal: Arch Ophthalmol Date: 2009-09
Authors: Geoffrey K Broadhead; Thomas Hong; John R Grigg; Peter McCluskey; Timothy E Schlub; Kimberly Spooner; Andrew A Chang Journal: Int Ophthalmol Date: 2020-07-14 Impact factor: 2.031
Authors: S Tammy Hsu; Atalie C Thompson; Sandra S Stinnett; Ulrich F O Luhmann; Lejla Vajzovic; Anupama Horne; Stefanie G Schuman; Cynthia A Toth; Scott W Cousins; Eleonora M Lad Journal: Ophthalmol Retina Date: 2019-03-21
Authors: Kimberly J Cocce; Sandra S Stinnett; Ulrich F O Luhmann; Lejla Vajzovic; Anupama Horne; Stefanie G Schuman; Cynthia A Toth; Scott W Cousins; Eleonora M Lad Journal: Am J Ophthalmol Date: 2018-03-15 Impact factor: 5.258
Authors: Dean Hallam; Joseph Collin; Sanja Bojic; Valeria Chichagova; Adriana Buskin; Yaobo Xu; Lucia Lafage; Elsje G Otten; George Anyfantis; Carla Mellough; Stefan Przyborski; Sameer Alharthi; Viktor Korolchuk; Andrew Lotery; Gabriele Saretzki; Martin McKibbin; Lyle Armstrong; David Steel; David Kavanagh; Majlinda Lako Journal: Stem Cells Date: 2017-10-09 Impact factor: 6.277
Authors: Atalie C Thompson; Ulrich F O Luhmann; Sandra S Stinnett; Lejla Vajzovic; Anupama Horne; Cynthia A Toth; Scott W Cousins; Eleonora M Lad Journal: Invest Ophthalmol Vis Sci Date: 2018-01-01 Impact factor: 4.799
Authors: Evan N Wong; Jehan D A De Soyza; David A Mackey; Ian J Constable; Fred K Chen Journal: Transl Vis Sci Technol Date: 2017-12-12 Impact factor: 3.283